Combined transcription-factor-based cell fate conversion strategy and pharmacological compounds enable partial dedifferentiation.
Brn2 and c-Myc reprogram radial glia-type stem cells into immature neuroepithelial cells.
Brn2/c-Myc reprogrammed neural cells differentiate into neural crest progeny.